Study Name: A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
24 locations found
- Study Name Unavailable
Location: Birmingham, Alabama 35243
- Study Name Unavailable
Location: Aurora, Colorado 80045
- Study Name Unavailable
Location: Atlanta, Georgia 30322
- Study Name Unavailable
Location: Indianapolis, Indiana 46202
- Study Name Unavailable
Location: Boston, Massachusetts 02114
- Study Name Unavailable
Location: Boston, Massachusetts 02215
- Study Name Unavailable
Location: Boston, Massachusetts 02115
- Study Name Unavailable
Location: Detroit, Michigan 48201
- Study Name Unavailable
Location: St Louis, Missouri 63110
- Study Name Unavailable
Location: New York, New York 10016
- Study Name Unavailable
Location: New York, New York 10065
- Study Name Unavailable
Location: Chapel Hill, North Carolina 27514
- Study Name Unavailable
Location: Philadelphia, Pennsylvania 19104
- Study Name Unavailable
Location: Pittsburgh, Pennsylvania 15213
- Study Name Unavailable
Location: Nashville, Tennessee 37232
- Study Name Unavailable
Location: Nashville, Tennessee 37203
- Study Name Unavailable
Location: Dallas, Texas 75246
- Study Name Unavailable
Location: Salt Lake City, Utah 84112
- Study Name Unavailable
Location: Tucson, Arizona 85724
- Study Name Unavailable
Location: Los Angeles, California 90095
- Study Name Unavailable
Location: San Francisco, California 94117
- Study Name Unavailable
Location: Santa Monica, California 90404
- Study Name Unavailable
Location: Portland, Oregon 97213
- Study Name Unavailable
Location: Seattle, Washington 98109
|